throbber
econazole | C18H15Cl3N2O - PubChem
`
`Page 1 of 30
`
`NIH
`
`U.S. National Library of Medicine
`
`National Center for Biotechnology Information
`
` Compound Summary for CID 3198
`
`Econazole
`
`Search Compounds
`
`
`
` Cite this Record
`
`
`
`
`
`
`
`
`
`
`
`
`
`STRUCTURE
`
`VENDORS
`
`DRUG INFO
`
`PHARMACOLOGY
`
`LITERATURE
`
`PATENTS
`
`BIOACTIVITIES
`
`PubChem CID:
`
`3198
`
`Chemical Names:
`
`Econazole; Ecostatin; 27220-47-9; Pevaryl; Gyno-pevaryl; Econazolum   
`
`More...
`
`Molecular Formula:
`
`Molecular Weight:
`
`C H Cl N O
`18
`15
`3
`2
`381.681 g/mol
`
`InChI Key:
`
`LEZWWPYKPKIXLL-UHFFFAOYSA-N
`
`Safety Summary:
`
`Laboratory Chemical Safety Summary (LCSS)
`
`Drug Information:
`
`Drug Indication
`
`FDA Orange Book
`
`Econazole is an imidazole derivative that is commonly used as a topical antifungal agent.
`
` from MeSH
`
`Econazole is only found in individuals that have used or taken this drug. It is a broad spectrum antimycotic with
`some action against Gram positive bacteria. It is used topically in dermatomycoses also orally and parenterally.
`[PubChem]Econazole interacts with 14-alpha demethylase, a cytochrome P-450 enzyme necessary to convert
`lanosterol to ergosterol. As ergosterol is an essential component of the fungal cell membrane, inhibition of its
`synthesis results in increased cellular permeability causing leakage of cellular contents. Econazole may also
`inhibit endogenous respiration, interact with membrane phospholipids, inhibit the transformation of yeasts to
`mycelial forms, inhibit purine uptake, and impair triglyceride and/or phospholipid biosynthesis.
` Metabolite Description from Human Metabolome Database
`
`PUBCHEM
`
`
`
`COMPOUND
`
`
`
`ECONAZOLE
`
`Create Date: 2005-03-25
`
`https://pubchem.ncbi.nlm.nih.gov/compound/3198
`
`5/26/2017
`
`MYLAN - Ex. 1026, p. 1
`
`

`

`econazole | C18H15Cl3N2O - PubChem
`
`Page 2 of 30
`
` Contents
`1 2D Structure
`
`2 3D Conformer
`
`3 Names and Identifiers
`
`4 Chemical and Physical Properties
`
`5 Related Records
`
`6 Chemical Vendors
`
`7 Drug and Medication Information
`
`8 Pharmacology and Biochemistry
`
`9 Safety and Hazards
`
`10 Toxicity
`
`11 Literature
`
`12 Patents
`
`13 Biomolecular Interactions and Pathways
`
`14 Biological Test Results
`
`15 Classification
`
`16 Information Sources
`
`https://pubchem.ncbi.nlm.nih.gov/compound/3198
`
`5/26/2017
`
`MYLAN - Ex. 1026, p. 2
`
`

`

`econazole | C18H15Cl3N2O - PubChem
`
`Page 3 of 30
`
`1 2D Structure
`
` Search
`
` Download
`
` Get Image
`
` Magnify
`
` from PubChem
`
`https://pubchem.ncbi.nlm.nih.gov/compound/3198
`
`5/26/2017
`
`MYLAN - Ex. 1026, p. 3
`
`

`

`econazole | C18H15Cl3N2O - PubChem
`
`Page 4 of 30
`
`2 3D Conformer
`
` Search
`
` Download
`
` Get Image
`
`CLICK TO LOAD...
`
` Magnify
`
` Show Hydrogens
`
` Show Atoms
`
` Animate
`
` from PubChem
`
`https://pubchem.ncbi.nlm.nih.gov/compound/3198
`
`5/26/2017
`
`MYLAN - Ex. 1026, p. 4
`
`

`

`econazole | C18H15Cl3N2O - PubChem
`
`Page 5 of 30
`
`3 Names and Identifiers
`
`3.1 Computed Descriptors
`
`3.1.1 IUPAC Name
`
`1-[2-[(4-chlorophenyl)methoxy]-2-(2,4-dichlorophenyl)ethyl]imidazole
`
` from PubChem
`
`3.1.2 InChI
`
`InChI=1S/C18H15Cl3N2O/c19-14-3-1-13(2-4-14)11-24-18(10-23-8-7-22-12-23)16-6-5-15(20)9-17(16)
`21/h1-9,12,18H,10-11H2
`
`3.1.3 InChI Key
`
`LEZWWPYKPKIXLL-UHFFFAOYSA-N
`
`3.1.4 Canonical SMILES
`
`C1=CC(=CC=C1COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl)Cl
`
`3.2 Molecular Formula
`
`C H Cl N O
`18
`15
`3
`2
`
`3.3 Other Identifiers
`
`3.3.1 CAS
`
` from PubChem
`
` from PubChem
`
` from PubChem
`
` from PubChem
`
`27220-47-9
` from ChemIDplus, DrugBank, European Chemicals Agency - ECHA, Human Metabolome Database
`
`68797-30-8
`
`https://pubchem.ncbi.nlm.nih.gov/compound/3198
`
`5/26/2017
`
`MYLAN - Ex. 1026, p. 5
`
`

`

`econazole | C18H15Cl3N2O - PubChem
`
`Page 6 of 30
`
` from European Chemicals Agency - ECHA
`
` from European Chemicals Agency - ECHA
`
` from European Chemicals Agency - ECHA
`
`econazole
`
`chemical compound
`
` from Wikipedia
`
`11. Nitrate, Econazole
`12. Pevaryl
`
`3.3.2 EC Number
`
`272-294-0
`
`248-341-6
`
`3.3.3 Wikipedia
`
`Title
`
`Description
`
`3.4 Synonyms
`
`3.4.1 MeSH Synonyms
`
`1. Econazole
`2. Econazole Nitrate
`3. Ekonazole
`4. Gyno Pervaryl 150
`5. Gyno Pevaril
`6. Gyno Pevaryl
`7. Gyno-Pervaryl 150
`8. Gyno-Pevaril
`9. Gyno-Pevaryl
`10. GynoPevaril
`
` from MeSH
`
`
`
`31. 1-{2-[(4-chlorophenyl)methoxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole
`32. BSPBio_000268
`
`
`3.4.2 Depositor-Supplied Synonyms
`
`1. econazole
`2. Ecostatin
`
`
`(+-)-Econazole
`11.
`12. Ecostatin cream
`
`21. Prestwick3_000304
`22. Spectrum2_001439
`
`https://pubchem.ncbi.nlm.nih.gov/compound/3198
`
`5/26/2017
`
`MYLAN - Ex. 1026, p. 6
`
`

`

`econazole | C18H15Cl3N2O - PubChem
`
`Page 7 of 30
`
`3. 27220-47-9
`4. Pevaryl
`5. Gyno-pevaryl
`6. Econazolum
`7. Palavale
`8. Econazol
`9. Spectazole
`10.
`Ifenec
`
`
`13. Spectazole cream
`14. Gyno-Pevaryl 150
`15. Spectrum_001223
`16. Ecostatin Vaginal Ovules
`17. Econazole (USAN/INN)
`18. Prestwick0_000304
`19. Prestwick1_000304
`20. Prestwick2_000304
`
`23. Spectrum3_001467
`24. Spectrum4_000446
`25. Spectrum5_001033
`26. NSC187789
`27. CHEMBL808
`28. NSC 187789
`29. AC1L1FE8
`30. AC1Q3JJ8
`
`33. BSPBio_002993
`34. KBioGR_000832
`35. KBioSS_001703
`36. SQ 13050
`37. DivK1c_000113
`38. SPBio_001578
`39. SPBio_002487
`40. BPBio1_000296
`
`
` from PubChem
`
`https://pubchem.ncbi.nlm.nih.gov/compound/3198
`
`5/26/2017
`
`MYLAN - Ex. 1026, p. 7
`
`

`

`econazole | C18H15Cl3N2O - PubChem
`
`Page 8 of 30
`
`4 Chemical and Physical Properties
`
`4.1 Computed Properties
`
`Property Name
`
`Molecular Weight
`
`Hydrogen Bond Donor Count
`
`Hydrogen Bond Acceptor Count
`
`Rotatable Bond Count
`
`Complexity
`
`CACTVS Substructure Key Fingerprint
`
`Topological Polar Surface Area
`
`Monoisotopic Mass
`
`Exact Mass
`
`XLogP3
`
`Compound Is Canonicalized
`
`Formal Charge
`
`Heavy Atom Count
`
`Defined Atom Stereocenter Count
`
`Undefined Atom Stereocenter Count
`
`Defined Bond Stereocenter Count
`
`Undefined Bond Stereocenter Count
`
`Isotope Atom Count
`
`Covalently-Bonded Unit Count
`
`4.2 Experimental Properties
`
`4.2.1 Physical Description
`
`Property Value
`
`381.681 g/mol
`
`0
`
`2
`
`6
`
`379
`
`AAADccB7IAAGAAAAAAAAAAAAAAAAAWAAAAAw
`YAAAAAAAAAAB0AAAHgIAAAAADBbhmiY9kJcMFA
`CgAjBnZAACgC0xF6AJyAAYOoiKbiKBuxmXMAAswA
`OYqCeQwKAOBAAAAACBAAAIAAAAAQIAAAAAAAA
`A
`
`27 A^2
`
`380.025 g/mol
`
`380.025 g/mol
`
`5.3
`
`true
`
`0
`
`24
`
`0
`
`1
`
`0
`
`0
`
`0
`
`1
`
` from PubChem
`
`https://pubchem.ncbi.nlm.nih.gov/compound/3198
`
`5/26/2017
`
`MYLAN - Ex. 1026, p. 8
`
`

`

`econazole | C18H15Cl3N2O - PubChem
`
`Page 9 of 30
`
`Solid
`
`4.2.2 Melting Point
`
` from Human Metabolome Database
`
`162
`Godefroi, E.F. and Heeres, J.; U.S. Patent 3,717,655; February 20,1973; assigned to Jansen Pharmaceutica NV, Belgium.
` from DrugBank
`
` from Human Metabolome Database
`
` from DrugBank, Human Metabolome Database
`
`4.2.3 Solubility
`
`1.48e-03 g/L
`
`4.2.4 LogP
`
`5.5
`
`4.3 Spectral Properties
`
`4.3.1 GC-MS
`
`
`
`
`
`1 of 2
`
`
`
`
`
`NIST Number
`
`Library
`
`Total Peaks
`
`m/z Top Peak
`
`m/z 2nd Highest
`
`m/z 3rd Highest
`
`Thumbnail
`
`193280
`
`Main library
`
`124
`
`125
`
`127
`
`81
`
`CLICK TO LOAD...
`
`https://pubchem.ncbi.nlm.nih.gov/compound/3198
`
`5/26/2017
`
`MYLAN - Ex. 1026, p. 9
`
`

`

`econazole | C18H15Cl3N2O - PubChem
`
`Page 10 of 30
`
` from NIST
`
` from Human Metabolome Database
`
`
`
`
`
`1 of 2
`
`
`
`
`
`4.3.2 MS-MS
`
`1. MS-MS Spectrum 84288
`2. MS-MS Spectrum 84289
`3. MS-MS Spectrum 84290
`4. MS-MS Spectrum 146100
`5. MS-MS Spectrum 146101
`6. MS-MS Spectrum 146102
`7. MS-MS Spectrum 216835
`
`NIST Number
`
`Instrument Type
`
`Collision Energy
`
`Spectrum Type
`
`Precursor Type
`
`Precursor m/z
`
`Total Peaks
`
`m/z Top Peak
`
`m/z 2nd Highest
`
`m/z 3rd Highest
`
`Thumbnail
`
`1144596
`
`IT/ion trap
`
`0
`
`MS2
`
`[M+H]+
`
`381.0323
`
`9
`
`124.9
`
`192.9
`
`125.9
`
`CLICK TO LOAD...
`
`https://pubchem.ncbi.nlm.nih.gov/compound/3198
`
`5/26/2017
`
`MYLAN - Ex. 1026, p. 10
`
`

`

`econazole | C18H15Cl3N2O - PubChem
`
`Page 11 of 30
`
` from NIST
`
`https://pubchem.ncbi.nlm.nih.gov/compound/3198
`
`5/26/2017
`
`MYLAN - Ex. 1026, p. 11
`
`

`

`econazole | C18H15Cl3N2O - PubChem
`
`Page 12 of 30
`
`5 Related Records
`
`CLICK TO LOAD...
`
`5.1 Related Compounds with Annotation
`
`CLICK TO LOAD...
`
`5.2 Related Compounds
`
`Same Connectivity
`
`3 records
`
`Same Parent, Connectivity
`
`21 records
`
`Same Parent, Exact
`
`Mixtures, Components, and
`Neutralized Forms
`
`Similar Compounds
`
`Similar Conformers
`
`16 records
`
`44 records
`
`1142 records
`
`344 records
`
` from NCBI
`
` from PubChem
`
` from PubChem
`
`https://pubchem.ncbi.nlm.nih.gov/compound/3198
`
`5/26/2017
`
`MYLAN - Ex. 1026, p. 12
`
`

`

`econazole | C18H15Cl3N2O - PubChem
`
`Page 13 of 30
`
`5.3 Substances
`
`5.3.1 Related Substances
`
`All
`
`Same
`
`Mixture
`
`340 records
`
`129 records
`
`211 records
`
`5.3.2 Substances by Category
`
`CLICK TO LOAD...
`
`5.4 Entrez Crosslinks
`
`PubMed
`
`Taxonomy
`
`Gene
`
`281 records
`
`130 records
`
`10 records
`
` from PubChem
`
` from PubChem
`
` from PubChem
`
`https://pubchem.ncbi.nlm.nih.gov/compound/3198
`
`5/26/2017
`
`MYLAN - Ex. 1026, p. 13
`
`

`

`econazole | C18H15Cl3N2O - PubChem
`
`Page 14 of 30
`
`6 Chemical Vendors
`
`CLICK TO LOAD...
`
` from PubChem
`
`https://pubchem.ncbi.nlm.nih.gov/compound/3198
`
`5/26/2017
`
`MYLAN - Ex. 1026, p. 14
`
`

`

`econazole | C18H15Cl3N2O - PubChem
`
`Page 15 of 30
`
`7 Drug and Medication Information
`
`7.1 Drug Indication
`
`For topical application in the treatment of tinea pedis, tinea cruris, and tinea corporis caused by Trichophyton
`rubrum, Trichophyton mentagrophytes, Trichophyton tonsurans, Microsporum canis, Microsporum audouini,
`Microsporum gypseum, and Epidermophyton floccosum, in the treatment of cutaneous candidiasis, and in the
`treatment of tinea versicolor.
`
` from DrugBank
`
`7.2 FDA Orange Book
`
`7.2.1 Prescription Drug Products
`
`Drug Ingredient
`
`Proprietary Name
`
`Applicant
`
`ECONAZOLE NITRATE
`
`ECOZA
`
`EXELTIS SUISSE (Application Number: N205175. Patent: 5993830)
`
` from FDA Orange Book
`
`7.2.2 Discontinued Drug Products
`
`Drug Ingredient
`
`Proprietary Name
`
`Applicant
`
`ECONAZOLE NITRATE
`
`SPECTAZOLE
`
`ALVOGEN MALTA (Application Number: N018751)
`
` from FDA Orange Book
`
`7.3 Drugs at PubMed Health
`
`Drugs at PubMed Health: 1 of 2
`
`Drug Name
`
`Description
`
`Drug Classes
`
`Econazole (Topical route) (Ecoza)
`
`Treats skin fungus infections. This is an antifungal medicine.
`
`Antifungal
`
` from PubMed Health
`
`https://pubchem.ncbi.nlm.nih.gov/compound/3198
`
`5/26/2017
`
`MYLAN - Ex. 1026, p. 15
`
`

`

`econazole | C18H15Cl3N2O - PubChem
`
`Page 16 of 30
`
`Drugs at PubMed Health: 2 of 2
`
`Drug Name
`
`Notes
`
`Spectazole
`
`See Econazole (Topical route)
`
` from PubMed Health
`
`https://pubchem.ncbi.nlm.nih.gov/compound/3198
`
`5/26/2017
`
`MYLAN - Ex. 1026, p. 16
`
`

`

`econazole | C18H15Cl3N2O - PubChem
`
`Page 17 of 30
`
`8 Pharmacology and Biochemistry
`
`8.1 Pharmacology
`
`Econazole is an antifungal medication related to fluconazole (Diflucan), ketoconazole (Nizoral), itraconazole
`(Sporanox), and clotrimazole (Lotrimin, Mycelex). Econazole prevents fungal organisms from producing vital
`substances required for growth and function. This medication is effective only for infections caused by fungal
`organisms. It will not work for bacterial or viral infections.
`
` from DrugBank
`
`8.2 MeSH Pharmacological Classification
`
`14-alpha Demethylase Inhibitors
`Compounds that specifically inhibit STEROL 14-DEMETHYLASE. A variety of azole-derived ANTIFUNGAL
`AGENTS act through this mechanism. See a list of PubChem compounds matching this category.
` from MeSH
`
`Antifungal Agents
`Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES,
`INDUSTRIAL because they defend against fungi present in human or animal tissues. See a list of PubChem
`compounds matching this category.
`
` from MeSH
`
`8.3 ATC Code
`
`D01AC03 - Econazole < D01AC - Imidazole and triazole derivatives < D01A - Antifungals for topical use < D01
`- Antifungals for dermatological use < D - Dermatologicals
`
` from WHO ATC
`
`G01AF05 - Econazole < G01AF - Imidazole derivatives < G01A - Antiinfectives and antiseptics, excl.
`combinations with corticosteroids < G01 - Gynecological antiinfectives and antiseptics < G - Genito urinary
`system and sex hormones More information...
`
` from WHO ATC
`
`8.4 Absorption, Distribution and Excretion
`
`After topical application to the skin of normal subjects, systemic absorption of econazole nitrate is extremely
`low. Although most of the applied drug remains on the skin surface, drug concentrations were found in the
`stratum corneum which, by far, exceeded the minimum inhibitory concentration for dermatophytes.
` from DrugBank
`
`https://pubchem.ncbi.nlm.nih.gov/compound/3198
`
`5/26/2017
`
`MYLAN - Ex. 1026, p. 17
`
`

`

`econazole | C18H15Cl3N2O - PubChem
`
`Page 18 of 30
`
`8.5 Metabolism/Metabolites
`
`Hepatic.
`
`8.6 Mechanism of Action
`
` from DrugBank
`
`Econazole interacts with 14-α demethylase, a cytochrome P-450 enzyme necessary to convert lanosterol to
`ergosterol. As ergosterol is an essential component of the fungal cell membrane, inhibition of its synthesis
`results in increased cellular permeability causing leakage of cellular contents. Econazole may also inhibit
`endogenous respiration, interact with membrane phospholipids, inhibit the transformation of yeasts to
`mycelial forms, inhibit purine uptake, and impair triglyceride and/or phospholipid biosynthesis.
` from DrugBank
`
`8.7 Human Metabolite Information
`
`8.7.1 Metabolite Description
`
`Econazole is only found in individuals that have used or taken this drug. It is a broad spectrum antimycotic
`with some action against Gram positive bacteria. It is used topically in dermatomycoses also orally and
`parenterally. [PubChem]Econazole interacts with 14-alpha demethylase, a cytochrome P-450 enzyme
`necessary to convert lanosterol to ergosterol. As ergosterol is an essential component of the fungal cell
`membrane, inhibition of its synthesis results in increased cellular permeability causing leakage of cellular
`contents. Econazole may also inhibit endogenous respiration, interact with membrane phospholipids, inhibit
`the transformation of yeasts to mycelial forms, inhibit purine uptake, and impair triglyceride and/or
`phospholipid biosynthesis.
`
` from Human Metabolome Database
`
`8.7.2 Biofluid Locations
`
`1. Blood
`2. Urine
`
`8.7.3 Cellular Locations
`
`Membrane
`
` from Human Metabolome Database
`
` from Human Metabolome Database
`
`https://pubchem.ncbi.nlm.nih.gov/compound/3198
`
`5/26/2017
`
`MYLAN - Ex. 1026, p. 18
`
`

`

`econazole | C18H15Cl3N2O - PubChem
`
`Page 19 of 30
`
`9 Safety and Hazards
`
`9.1 Hazards Identification
`
`9.1.1 GHS Classification
`
`Signal: Warning
`GHS Hazard Statements
`Aggregated GHS information from 4 notifications provided by 53 companies to the ECHA C&L Inventory.
`
`H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral - Category 4]
`
`Information may vary between notifications depending on impurities, additives, and other factors. The
`percentage value in parenthesis indicates the notified classification ratio from all companies. Only Hazard
`Codes with percentage values above 10% are shown.
`
`Precautionary Statement Codes
`P264, P270, P301+P312, P330, and P501
`(The corresponding statement to each P-code can be found here.)
`
` from European Chemicals Agency - ECHA
`
`https://pubchem.ncbi.nlm.nih.gov/compound/3198
`
`5/26/2017
`
`MYLAN - Ex. 1026, p. 19
`
`

`

`econazole | C18H15Cl3N2O - PubChem
`
`Page 20 of 30
`
`10 Toxicity
`
`10.1 Toxicological Information
`
`10.1.1 Toxicity Summary
`
`Overdosage of econazole in humans has not been reported to date. In mice, rats guinea pigs and dogs, the
`oral LD 50 values were found to be 462, 668, 272, and > 160 mg/kg, respectively.
`
` from DrugBank
`
`https://pubchem.ncbi.nlm.nih.gov/compound/3198
`
`5/26/2017
`
`MYLAN - Ex. 1026, p. 20
`
`

`

`econazole | C18H15Cl3N2O - PubChem
`
`Page 21 of 30
`
`11 Literature
`
`11.1 Depositor Provided PubMed Citations
`
`CLICK TO LOAD...
`
`11.2 NLM Curated PubMed Citations
`
`CLICK TO LOAD...
`
` from PubChem
`
` from PubChem
`
`11.3 Synthesis References
`
`Godefroi, E.F. and Heeres, J.; U.S. Patent 3,717,655; February 20,1973; assigned to Jansen Pharmaceutica NV,
`Belgium.
`
` from DrugBank
`
`https://pubchem.ncbi.nlm.nih.gov/compound/3198
`
`5/26/2017
`
`MYLAN - Ex. 1026, p. 21
`
`

`

`econazole | C18H15Cl3N2O - PubChem
`
`Page 22 of 30
`
`12 Patents
`
`12.1 Depositor-Supplied Patent Identifiers
`
`CLICK TO LOAD...
`
` from PubChem
`
`https://pubchem.ncbi.nlm.nih.gov/compound/3198
`
`5/26/2017
`
`MYLAN - Ex. 1026, p. 22
`
`

`

`econazole | C18H15Cl3N2O - PubChem
`
`Page 23 of 30
`
`13 Biomolecular Interactions and Pathways
`
`13.1 DrugBank Interactions
`
`Target
`
`Action
`
`General
`Function
`
`Specific
`Function
`
`Lanosterol 14-alpha demethylase
`
`antagonist
`
`Sterol 14-demethylase activity
`
`Catalyzes C14-demethylation of lanosterol which is critical for ergosterol biosynthesis. It
`transforms lanosterol into 4,4'-dimethyl cholesta-8,14,24-triene-3-beta-ol.
`
`Gene Name
`
`ERG11
`
`GenBank
`Gene
`
`GenBank
`Protein
`
`Reference
`
`Reference
`
`X13296
`
`578119
`
`Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug
`targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. Pubmed
`
`Warrilow AG, Martel CM, Parker JE, Melo N, Lamb DC, Nes WD, Kelly DE, Kelly SL: Azole
`Binding Properties of Candida albicans Sterol 14-{alpha} Demethylase (CaCYP51). Antimicrob
`Agents Chemother. 2010 Jul 12. Pubmed
`
`Reference
`
`Strushkevich N, Usanov SA, Park HW: Structural basis of human CYP51 inhibition by
`antifungal azoles. J Mol Biol. 2010 Apr 9;397(4):1067-78. Epub 2010 Feb 10. Pubmed
`
`Reference
`
`Reference
`
`Jackson CJ, Lamb DC, Kelly DE, Kelly SL: Bactericidal and inhibitory effects of azole antifungal
`compounds on Mycobacterium smegmatis. FEMS Microbiol Lett. 2000 Nov 15;192(2):159-62.
`Pubmed
`
`Pietila MP, Vohra PK, Sanyal B, Wengenack NL, Raghavakaimal S, Thomas CF Jr: Cloning and
`characterization of CYP51 from Mycobacterium avium. Am J Respir Cell Mol Biol. 2006
`Aug;35(2):236-42. Epub 2006 Mar 16. Pubmed
`
`Reference
`
`Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE:
`The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. Pubmed
`
` from DrugBank
`
`Enzyme
`
`Cytochrome P450 19A1
`
`Action
`
`inhibitor
`
`General
`Function
`
`Oxygen binding
`
`Catalyzes the formation of aromatic C18 estrogens from C19 androgens.
`
`https://pubchem.ncbi.nlm.nih.gov/compound/3198
`
`5/26/2017
`
`MYLAN - Ex. 1026, p. 23
`
`

`

`econazole | C18H15Cl3N2O - PubChem
`
`Page 24 of 30
`
`Specific
`Function
`
`Gene
`Name
`
`GenBank
`Gene
`
`GenBank
`Protein
`
`Reference
`
`CYP19A1
`
`M22246
`
`179002
`
`Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R,
`Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450
`enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38
`(Database issue):D237-43. Epub 2009 Nov 24. Pubmed
`
` from DrugBank
`
`Enzyme
`
`Cytochrome P450 2E1
`
`Action
`
`inhibitor
`
`General
`Function
`
`Specific
`Function
`
`Gene
`Name
`
`GenBank
`Gene
`
`GenBank
`Protein
`
`Reference
`
`Steroid hydroxylase activity
`
`Metabolizes several precarcinogens, drugs, and solvents to reactive metabolites. Inactivates a
`number of drugs and xenobiotics and also bioactivates many xenobiotic substrates to their
`hepatotoxic or carcinogenic forms.
`
`CYP2E1
`
`J02625
`
`181360
`
`Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R,
`Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450
`enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38
`(Database issue):D237-43. Epub 2009 Nov 24. Pubmed
`
` from DrugBank
`
`View all (4) DrugBank Interactions entries
`
`https://pubchem.ncbi.nlm.nih.gov/compound/3198
`
`5/26/2017
`
`MYLAN - Ex. 1026, p. 24
`
`

`

`econazole | C18H15Cl3N2O - PubChem
`
`Page 25 of 30
`
`14 Biological Test Results
`
`14.1 BioAssay Results
`
`CLICK TO LOAD...
`
` from PubChem
`
`https://pubchem.ncbi.nlm.nih.gov/compound/3198
`
`5/26/2017
`
`MYLAN - Ex. 1026, p. 25
`
`

`

`econazole | C18H15Cl3N2O - PubChem
`
`Page 26 of 30
`
`15 Classification
`
`15.1 Ontologies
`
`15.1.1 MeSH Tree
`
`CLICK TO LOAD...
`
`15.1.2 ChEBI Ontology
`
`CLICK TO LOAD...
`
`15.1.3 KEGG: USP
`
`CLICK TO LOAD...
`
` from MeSH
`
` from ChEBI
`
`https://pubchem.ncbi.nlm.nih.gov/compound/3198
`
`5/26/2017
`
`MYLAN - Ex. 1026, p. 26
`
`

`

`econazole | C18H15Cl3N2O - PubChem
`
`Page 27 of 30
`
`15.1.4 KEGG: ATC
`
`CLICK TO LOAD...
`
`15.1.5 KEGG: Antiinfectives
`
`CLICK TO LOAD...
`
`15.1.6 KEGG: Risk Category of Japanese OTC Drugs
`
`CLICK TO LOAD...
`
` from KEGG
`
` from KEGG
`
` from KEGG
`
`https://pubchem.ncbi.nlm.nih.gov/compound/3198
`
`5/26/2017
`
`MYLAN - Ex. 1026, p. 27
`
`

`

`econazole | C18H15Cl3N2O - PubChem
`
`Page 28 of 30
`
`15.1.7 WHO ATC Classification System
`
`CLICK TO LOAD...
`
`15.1.8 WIPO IPC
`
`CLICK TO LOAD...
`
` from KEGG
`
` from WHO ATC
`
` from WIPO
`
`https://pubchem.ncbi.nlm.nih.gov/compound/3198
`
`5/26/2017
`
`MYLAN - Ex. 1026, p. 28
`
`

`

`econazole | C18H15Cl3N2O - PubChem
`
`Page 29 of 30
`
`16 Information Sources
`
`1. ChemIDplus /source/ChemIDplus
`Econazole [USAN:INN:BAN]
`https://chem.nlm.nih.gov/chemidplus/sid/0027220479 https://chem.nlm.nih.gov/chemidplus/sid/0027220479
`
`2. DrugBank /source/DrugBank
`Econazole
`http://www.drugbank.ca/drugs/DB01127 http://www.drugbank.ca/drugs/DB01127
`http://www.drugbank.ca/drugs/DB01127#targets http://www.drugbank.ca/drugs/DB01127#targets
`http://www.drugbank.ca/drugs/DB01127#enzymes http://www.drugbank.ca/drugs/DB01127#enzymes
`
`3. European Chemicals Agency - ECHA /source/European Chemicals Agency - ECHA
`econazole
`https://echa.europa.eu/ https://echa.europa.eu/
`econazole
`https://echa.europa.eu/information-on-chemicals/cl-inventory-database/-/discli/details/120784
`https://echa.europa.eu/information-on-chemicals/cl-inventory-database/-/discli/details/120784
`
`4. Human Metabolome Database /source/Human Metabolome Database
`Econazole
`http://www.hmdb.ca/metabolites/HMDB15259 http://www.hmdb.ca/metabolites/HMDB15259
`
`5. FDA Orange Book /source/FDA Orange Book
`ECONAZOLE NITRATE
`http://www.fda.gov/Drugs/InformationOnDrugs/ucm129662.htm
`http://www.fda.gov/Drugs/InformationOnDrugs/ucm129662.htm
`
`6. NIST /source/NIST
`Econazole
`http://www.nist.gov/srd/nist1a.cfm http://www.nist.gov/srd/nist1a.cfm
`
`7. PubMed Health /source/PubMed Health
`Spectazole
`http://www.ncbi.nlm.nih.gov/pubmedhealth/PMHT0010072/
`http://www.ncbi.nlm.nih.gov/pubmedhealth/PMHT0010072/
`
`8. WHO ATC /source/WHO ATC
`http://www.whocc.no/atc/ http://www.whocc.no/atc/
`ATC Code
`http://www.whocc.no/atc_ddd_index/ http://www.whocc.no/atc_ddd_index/
`
`9. Wikipedia /source/Wikipedia
`econazole
`https://en.wikipedia.org/wiki/Econazole https://en.wikipedia.org/wiki/Econazole
`
`10. PubChem
`Data deposited in or computed by PubChem
`https://pubchem.ncbi.nlm.nih.gov https://pubchem.ncbi.nlm.nih.gov
`
`https://pubchem.ncbi.nlm.nih.gov/compound/3198
`
`5/26/2017
`
`MYLAN - Ex. 1026, p. 29
`
`

`

`econazole | C18H15Cl3N2O - PubChem
`
`Page 30 of 30
`
`11. MeSH /source/MeSH
`Econazole
`https://www.ncbi.nlm.nih.gov/mesh/68004464 https://www.ncbi.nlm.nih.gov/mesh/68004464
`MeSH Tree
`http://www.nlm.nih.gov/mesh/meshhome.html http://www.nlm.nih.gov/mesh/meshhome.html
`14-alpha Demethylase Inhibitors
`https://www.ncbi.nlm.nih.gov/mesh/68058888 https://www.ncbi.nlm.nih.gov/mesh/68058888
`Antifungal Agents
`https://www.ncbi.nlm.nih.gov/mesh/68000935 https://www.ncbi.nlm.nih.gov/mesh/68000935
`
`12. ChEBI /source/ChEBI
`ChEBI Ontology
`http://www.ebi.ac.uk/chebi/userManualForward.do#ChEBI%20Ontology
`http://www.ebi.ac.uk/chebi/userManualForward.do#ChEBI%20Ontology
`
`13. KEGG /source/KEGG
`USP
`http://www.genome.jp/dbget-bin/www_bget?brite:br08302 http://www.genome.jp/dbget-bin/www_bget?brite:br08302
`ATC
`http://www.genome.jp/dbget-bin/www_bget?brite:br08303 http://www.genome.jp/dbget-bin/www_bget?brite:br08303
`Antiinfectives
`http://www.genome.jp/dbget-bin/www_bget?brite:br08307 http://www.genome.jp/dbget-bin/www_bget?brite:br08307
`Risk category of Japanese OTC drugs
`http://www.genome.jp/dbget-bin/www_bget?brite:br08312 http://www.genome.jp/dbget-bin/www_bget?brite:br08312
`
`14. WIPO /source/WIPO
`International Patent Classification
`http://www.wipo.int/classifications/ipc/ http://www.wipo.int/classifications/ipc/
`
`15. NCBI
`LinkOut is a service that allows one to link directly from NCBI databases to a wide range of information and services
`beyond NCBI systems.
`https://www.ncbi.nlm.nih.gov/projects/linkout https://www.ncbi.nlm.nih.gov/projects/linkout
`
`https://pubchem.ncbi.nlm.nih.gov/compound/3198
`
`5/26/2017
`
`MYLAN - Ex. 1026, p. 30
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket